Drug Safety, Medical Device, And Laboratory Regulation
US Congress 117th Congress
Marijuana Data Collection Act [HB-3043]
To direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
HB-3043: Marijuana Data Collection Act
Sponsored by: Rep. Don Young
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 11/09/2021
S.1508: A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes.
Sponsored by: Sen. Roger Marshall
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
You have voted S.1508: A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes..
Gabriella Miller Kids First Research Act 2.0 [S.1521]
A bill to require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.
S.1521: Gabriella Miller Kids First Research Act 2.0
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
Marijuana Data Collection Act [S.1456]
A bill to direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
S.1456: Marijuana Data Collection Act
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
S.1435: Affordable Prescriptions for Patients Act of 2021
Sponsored by: Sen. Chuck Grassley
Committee On The Judiciary. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 07/29/2021
Stop Stalling Access to Affordable Medications [HB-2883]
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
HB-2883: Stop Stalling Access to Affordable Medications
Sponsored by: Rep. David Cicilline
Committee Consideration And Mark-up Session Held. on 09/29/2021
Prompt Approval of Safe Generic Drugs Act [HB-2831]
To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes.
HB-2831: Prompt Approval of Safe Generic Drugs Act
Sponsored by: Rep. Nanette Barragan
Referred To The Subcommittee On Health. on 04/27/2021
Elijah E. Cummings Lower Drug Costs Now Act [HB-3]
To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.
HB-3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Oversight And Investigations. on 04/27/2021
Lower Costs, More Cures Act of 2021 [HB-19]
To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes.
HB-19: Lower Costs, More Cures Act of 2021
Sponsored by: Rep. Steve Scalise
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 10/19/2021